Allovir, Inc.

CAMBRIDGE, MA How do I update this listing?

Allovir is based out of Cambridge. AlloVir, Inc. is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company���s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. The firm last filed a Form D notice of exempt offering of securities on 2019-05-22. The notice included securities offered of Equity

Create Alert

Contact Info

allovir, inc.
139 MAIN STREET, SUITE 500
CAMBRIDGE MA    02142

Business Phone: (617) 433-2605
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-05-22 D BIOTECHNOLOGY Equity 121,253,231 121,253,231 0
2018-10-02 D BIOTECHNOLOGY Equity 50,000,000 30,000,000 20,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANSBERT GADICKE subscription required
    DIRECTOR
DAVID HALLAL subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN WILSON subscription required
    DIRECTOR
JUAN VERA subscription required
    DIRECTOR
MALCOM BRENNER subscription required
    DIRECTOR
MORANA JOVAN-EMBIRICOS subscription required
    DIRECTOR
VIKAS SINHA subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments